Organ Regeneration is a complex biological process where damaged or lost tissues in an organ are restored to their original structure and function. Unlike simple tissue repair, regeneration involves the restoration of specific cell types and tissue architecture. Many organisms, particularly amphibians and certain invertebrates, exhibit remarkable abilities for organ regeneration, such as limb regeneration in salamanders or heart regeneration in zebrafish. The process of organ regeneration typically involves a sequence of events, including inflammation, cellular dedifferentiation, proliferation, and differentiation. Inflammation signals the immune system to remove damaged cells, while dedifferentiation allows mature cells to revert to a more primitive state capable of proliferation. Proliferation involves the rapid division of cells, and subsequent differentiation directs the formation of specific cell types required for functional restoration. Mammals, including humans, exhibit limited organ regeneration compared to some other species. Nevertheless, certain organs possess regenerative capacities to varying extents, such as the liver's ability to regenerate after partial removal. Stem cells, which have the potential to differentiate into various cell types, play a crucial role in the regeneration process. Research in regenerative medicine explores ways to enhance and stimulate these intrinsic regenerative abilities. Scientists investigate various factors influencing organ regeneration, including genetic and environmental factors. Understanding the molecular mechanisms and signaling pathways involved in regeneration is essential for developing therapeutic strategies to enhance regeneration or repair damaged tissues. Advances in stem cell research, tissue engineering, and regenerative medicine hold promise for developing innovative treatments for organ injuries, degenerative diseases, and congenital defects, ultimately aiming to restore organ function and improve the quality of life for individuals with organ-related disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States